
INVO Bioscience (NASDAQ:INVO) brought in sales totaling $162.60 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2959.58%, resulting in a loss of $2.77 million. In Q4, INVO Bioscience earned $97.02 thousand, and total sales reached $3.05 million.